{"id":"lumbar-puncture","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"Lumbar puncture involves inserting a needle into the spinal canal to collect cerebrospinal fluid for testing or to administer medication. It is used to diagnose conditions such as meningitis, encephalitis, and subarachnoid hemorrhage.","oneSentence":"Lumbar puncture is a diagnostic procedure, not a drug, and does not have a pharmacological mechanism.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:19:46.308Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT04759586","phase":"PHASE3","title":"Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-10-05","conditions":"Primary Mediastinal Large B-Cell Lymphoma","enrollment":244},{"nctId":"NCT06317662","phase":"PHASE2","title":"Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-06-05","conditions":"Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia","enrollment":153},{"nctId":"NCT06311227","phase":"PHASE2","title":"Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-12-16","conditions":"Recurrent Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia Variant","enrollment":20},{"nctId":"NCT07069699","phase":"PHASE1, PHASE2","title":"Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-10-13","conditions":"Burkitt Lymphoma, Double-Expressor Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements","enrollment":50},{"nctId":"NCT05828069","phase":"PHASE2","title":"A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-03-28","conditions":"Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis","enrollment":48},{"nctId":"NCT07012044","phase":"PHASE1","title":"A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-10-30","conditions":"Acute Myeloid Leukemia Post Cytotoxic Therapy, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia","enrollment":47},{"nctId":"NCT03144297","phase":"","title":"Intracranial Pressure vs Percentage Body Fat","status":"COMPLETED","sponsor":"Gloucestershire Hospitals NHS Foundation Trust","startDate":"2015-03","conditions":"Intracranial Pressure","enrollment":100},{"nctId":"NCT03984448","phase":"PHASE2, PHASE3","title":"Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-10-22","conditions":"Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Double-Expressor Lymphoma","enrollment":363},{"nctId":"NCT04530565","phase":"PHASE3","title":"Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-01-25","conditions":"B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1","enrollment":348},{"nctId":"NCT03739814","phase":"PHASE2","title":"Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-05-08","conditions":"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia","enrollment":84},{"nctId":"NCT03919071","phase":"PHASE2","title":"Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-02-20","conditions":"Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Anaplastic Ganglioglioma","enrollment":58},{"nctId":"NCT02143414","phase":"PHASE2","title":"Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-06-30","conditions":"Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1","enrollment":53},{"nctId":"NCT04609046","phase":"PHASE1","title":"Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-05-24","conditions":"Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System","enrollment":47},{"nctId":"NCT07241559","phase":"NA","title":"Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided 5% Dextrose Injection in Chronic Low Back Pain","status":"RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2025-11-01","conditions":"Chronic Low Back Pain","enrollment":75},{"nctId":"NCT06871410","phase":"PHASE1","title":"Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2026-03-02","conditions":"Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia","enrollment":26},{"nctId":"NCT05212272","phase":"NA","title":"MRI in High-Grade Glioma Patients Undergoing Chemoradiation","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2022-09-02","conditions":"High Grade Glioma","enrollment":16},{"nctId":"NCT01875588","phase":"","title":"Thinking and Memory Problems in People With HIV","status":"RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2013-07-08","conditions":"HIV Positive","enrollment":1150},{"nctId":"NCT05359211","phase":"PHASE1","title":"NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2022-12-08","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma","enrollment":27},{"nctId":"NCT05286684","phase":"NA","title":"Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis","status":"COMPLETED","sponsor":"Centre Oscar Lambret","startDate":"2023-01-04","conditions":"Breast Cancer","enrollment":7},{"nctId":"NCT07448610","phase":"PHASE4","title":"ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-07-01","conditions":"Spinal Muscular Atrophy","enrollment":36},{"nctId":"NCT07476781","phase":"NA","title":"CSF and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and CNS Metastases or no CNS Metastases","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2025-12-12","conditions":"Solid Tumor Malignancies, Brain Metastasases, Leptomeningeal Disease (LMD)","enrollment":60},{"nctId":"NCT06918431","phase":"PHASE2","title":"Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2025-10-10","conditions":"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Lymphoblastic Lymphoma","enrollment":53},{"nctId":"NCT06784726","phase":"PHASE2","title":"Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-09-04","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma","enrollment":27},{"nctId":"NCT07133997","phase":"PHASE1","title":"Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia","status":"NOT_YET_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-06-01","conditions":"Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia","enrollment":26},{"nctId":"NCT05453500","phase":"PHASE2","title":"Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"University of Washington","startDate":"2023-03-27","conditions":"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative","enrollment":30},{"nctId":"NCT03252912","phase":"NA","title":"Study in Leptomeningeal Metastases of Breast Cancer","status":"COMPLETED","sponsor":"Institut du Cancer de Montpellier - Val d'Aurelle","startDate":"2017-01-06","conditions":"Breast Cancer","enrollment":51},{"nctId":"NCT07468136","phase":"PHASE1, PHASE2","title":"Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-04-24","conditions":"Anaplastic Oligodendroglioma, Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4","enrollment":33},{"nctId":"NCT07110246","phase":"PHASE2","title":"Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-11-07","conditions":"BRAF V600 Mutation, Low-grade Glioma, Low Grade Glioma of Brain","enrollment":96},{"nctId":"NCT05292664","phase":"PHASE1","title":"Venetoclax Basket Trial for High Risk Hematologic Malignancies","status":"RECRUITING","sponsor":"Andrew E. Place, MD","startDate":"2023-03-29","conditions":"Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary, Myelodysplastic Syndromes, Previously Treated","enrollment":30},{"nctId":"NCT07466316","phase":"PHASE3","title":"A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)","status":"NOT_YET_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2026-06-22","conditions":"Rhabdomyosarcoma","enrollment":342},{"nctId":"NCT07459959","phase":"PHASE1, PHASE2","title":"LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-06-01","conditions":"Alzheimer s Disease","enrollment":40},{"nctId":"NCT07444580","phase":"PHASE1","title":"PrP-targeting siRNA Safety & Mechanism Study","status":"NOT_YET_RECRUITING","sponsor":"Broad Institute of MIT and Harvard","startDate":"2026-04","conditions":"Prion Disease","enrollment":30},{"nctId":"NCT07225985","phase":"PHASE1, PHASE2","title":"Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2026-05-01","conditions":"Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory T-Cell Non-Hodgkin Lymphoma","enrollment":50},{"nctId":"NCT07456358","phase":"NA","title":"Autoimmune Neurological Diseases and Those Secondary to Immunotherapy: Study of Immunological Mechanisms and Research Into Targets of Immune Attack","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-03-01","conditions":"Neurological Diseases, Auto Immune Disease","enrollment":160},{"nctId":"NCT03096743","phase":"NA","title":"Evaluating Raised Intracranial Pressure Using MR Elastography","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2017-01-10","conditions":"Idiopathic Intracranial Hypertension","enrollment":200},{"nctId":"NCT07447479","phase":"PHASE4","title":"Functional Outcomes After LumbOpenitoneal Shunt Placement UndeR Local Anesthesia for Patients With Idiopathic Normal preSsure Hydrocephalus (FLOURISH) Trial","status":"NOT_YET_RECRUITING","sponsor":"Institute for Clinical Effectiveness, Japan","startDate":"2026-04-01","conditions":"Idiopathic Normal Pressure Hydrocephalus (INPH)","enrollment":196},{"nctId":"NCT07444476","phase":"PHASE3","title":"A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam","status":"NOT_YET_RECRUITING","sponsor":"Biogen","startDate":"2026-04-03","conditions":"Spinal Muscular Atrophy","enrollment":90},{"nctId":"NCT06322602","phase":"NA","title":"Ommaya Reservoir Placement at the Time of Biopsy for Longitudinal Biomarker Collection in Patients With Brain Tumors","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-02-28","conditions":"Brain Neoplasms","enrollment":20},{"nctId":"NCT07444450","phase":"PHASE3","title":"A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec","status":"NOT_YET_RECRUITING","sponsor":"Biogen","startDate":"2026-09-04","conditions":"Muscular Atrophy, Spinal","enrollment":42},{"nctId":"NCT07442149","phase":"PHASE1","title":"An Investigational Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of A-005","status":"COMPLETED","sponsor":"Alumis Inc","startDate":"2024-04-22","conditions":"Healthy Volunteer","enrollment":135},{"nctId":"NCT07442929","phase":"","title":"Crystallization of LA and Adjuvant Mixtures in Cerebrospinal Fluid","status":"RECRUITING","sponsor":"Medical University Innsbruck","startDate":"2025-09-01","conditions":"Hydrocephalus","enrollment":10},{"nctId":"NCT07443514","phase":"NA","title":"Cognitive Impairment in Patients With Diffuse Large B-Cell Lymphoma","status":"RECRUITING","sponsor":"Institute of Oncology Ljubljana","startDate":"2022-01-01","conditions":"Diffuse Large B-Cell Lymphoma","enrollment":3},{"nctId":"NCT07354464","phase":"PHASE3","title":"Efficacy of Sphenopalatine Block Compared to Blood Patch in the Management of Post-dural Puncture Headaches","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2026-02-19","conditions":"PDPH, Post Dural Puncture Headache","enrollment":80},{"nctId":"NCT05866419","phase":"NA","title":"Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy","status":"RECRUITING","sponsor":"Alcyone Therapeutics, Inc","startDate":"2023-11-27","conditions":"Spinal Muscular Atrophy, Spine Deformity, Scoliosis","enrollment":90},{"nctId":"NCT07432113","phase":"NA","title":"Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Clinical Syndrome and Cerebrospinal Fluid Parameters: a Diagnostic Stewardship Proposal.","status":"NOT_YET_RECRUITING","sponsor":"Federal University of Health Science of Porto Alegre","startDate":"2026-03-16","conditions":"Meningitis, Encephalitic Infection, Encephalitis","enrollment":182},{"nctId":"NCT03263572","phase":"PHASE2","title":"Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-11-29","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression","enrollment":90},{"nctId":"NCT06410820","phase":"NA","title":"Ultrasound Guided Versus Land-mark Method for Spinal Anesthesia in Super Obesity Parturients","status":"COMPLETED","sponsor":"Karaman Training and Research Hospital","startDate":"2024-05-16","conditions":"Obesity, Morbid","enrollment":60},{"nctId":"NCT03504644","phase":"PHASE1, PHASE2","title":"Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2018-08-13","conditions":"Recurrent Adult Lymphoblastic Lymphoma, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma","enrollment":40},{"nctId":"NCT06247787","phase":"PHASE1","title":"A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2025-02-04","conditions":"Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Myelodysplastic Syndrome, Recurrent Juvenile Myelomonocytic Leukemia","enrollment":36},{"nctId":"NCT05577754","phase":"PHASE2","title":"Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2022-11-28","conditions":"Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)","enrollment":20},{"nctId":"NCT06368817","phase":"PHASE2","title":"A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2024-10-22","conditions":"Basal Ganglia Germinoma, Central Nervous System Germinoma, Diabetes Insipidus","enrollment":240},{"nctId":"NCT02981628","phase":"PHASE2","title":"Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2017-06-19","conditions":"Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma, Refractory B Acute Lymphoblastic Leukemia","enrollment":80},{"nctId":"NCT06475235","phase":"PHASE1","title":"Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-10-18","conditions":"Lymphoma, Primary Central Nervous System Lymphoma","enrollment":15},{"nctId":"NCT07409220","phase":"NA","title":"The Use of an Audio-visual Method in Counseling for Pediatric Lumbar Puncture Procedure","status":"RECRUITING","sponsor":"Oman Ministry of Health","startDate":"2025-01-31","conditions":"Meningitis in Children","enrollment":154},{"nctId":"NCT06878014","phase":"PHASE4","title":"Comparing the Safety and Effectiveness of Different Doses of Morphine Administered in Spinal Anethesia for Pain Relief After Hip Replacement Surgery","status":"RECRUITING","sponsor":"Medical University of Silesia","startDate":"2025-03-04","conditions":"Analgesics, Opioid, Anesthesia, Spinal, Total Hip Replacement","enrollment":120},{"nctId":"NCT05654363","phase":"","title":"Observational Retrospective Study on Spinal Analgesia in Laparoscopic and Laparotomic Hysterectomy","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-03-13","conditions":"Pain, Postoperative, Hysterectomy, Morphine","enrollment":670},{"nctId":"NCT04012411","phase":"NA","title":"Study of BDNF Pathway Biomarkers in the Cerebrospinal Fluid in Patients With Huntington's Disease","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2020-03-03","conditions":"Huntington Disease","enrollment":135},{"nctId":"NCT05419076","phase":"PHASE2","title":"A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-06-10","conditions":"Lung Cancer, Lung Cancer Metastatic, Brain Metastases","enrollment":62},{"nctId":"NCT05707442","phase":"PHASE3","title":"Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-02-16","conditions":"Idiopathic Intracranial Hypotension, Venous Sinus Stenosis","enrollment":74},{"nctId":"NCT07400068","phase":"","title":"PLDD With or Without Transforaminal Epidural Steroid Injection in Lumbar Disc Herniation","status":"NOT_YET_RECRUITING","sponsor":"Mersin University","startDate":"2026-03-01","conditions":"Lumbar Disc Herniation, Lumbar Radiculopathy","enrollment":88},{"nctId":"NCT07398599","phase":"NA","title":"Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Nanchang University","startDate":"2026-02-15","conditions":"Leptomeningeal Metastasis, Lung Neoplasms, Non-Small Cell Lung Cancer","enrollment":30},{"nctId":"NCT04872790","phase":"PHASE1","title":"Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia","status":"RECRUITING","sponsor":"OHSU Knight Cancer Institute","startDate":"2022-09-02","conditions":"B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Mixed Phenotype Acute Leukemia","enrollment":20},{"nctId":"NCT05121012","phase":"","title":"Synaptic Loss in Multiple System Atrophy","status":"RECRUITING","sponsor":"University of Exeter","startDate":"2021-09-01","conditions":"Multiple System Atrophy, Progressive Supranuclear Palsy (PSP)","enrollment":36},{"nctId":"NCT07398170","phase":"NA","title":"Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggressive Meningiomas: Proof-of-concept Study","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2026-03","conditions":"Meningioma","enrollment":15},{"nctId":"NCT06617429","phase":"PHASE3","title":"Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ultragenyx Pharmaceutical Inc","startDate":"2024-12-03","conditions":"Angelman Syndrome","enrollment":129},{"nctId":"NCT05854433","phase":"","title":"Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2023-04-26","conditions":"Myotonic Dystrophy Type 2, Myotonic Dystrophy Type 1","enrollment":100},{"nctId":"NCT06296745","phase":"PHASE2","title":"Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib.","status":"RECRUITING","sponsor":"Guangzhou Medical University","startDate":"2025-09-01","conditions":"Leptomeningeal Metastasis","enrollment":36},{"nctId":"NCT05130840","phase":"NA","title":"Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-07-13","conditions":"Breast Cancer","enrollment":9},{"nctId":"NCT04447027","phase":"PHASE1","title":"Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2020-12-17","conditions":"Cutaneous T-Cell Lymphoma, Mature T-cell Malignancies, Peripheral T-Cell Lymphoma","enrollment":26},{"nctId":"NCT06895473","phase":"PHASE2","title":"Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome","status":"RECRUITING","sponsor":"OHSU Knight Cancer Institute","startDate":"2025-06-04","conditions":"Hematopoietic and Lymphatic System Neoplasm","enrollment":26},{"nctId":"NCT07214844","phase":"NA","title":"A Prospective Study to Evaluate the Efficacy of Iovera Lumbar Medial Branch Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Chronic Low Back Pain","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2026-02","conditions":"Low Back Pain, Chronic","enrollment":110},{"nctId":"NCT04994808","phase":"PHASE2","title":"Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2023-08-11","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndrome","enrollment":23},{"nctId":"NCT03771898","phase":"PHASE2","title":"A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shire","startDate":"2019-05-13","conditions":"Metachromatic Leukodystrophy (MLD)","enrollment":36},{"nctId":"NCT05269238","phase":"NA","title":"Improvement of the Performance of Lumbar Punctures After Training Students With an Augmented Reality SIMulator","status":"COMPLETED","sponsor":"University Hospital, Strasbourg, France","startDate":"2021-12-02","conditions":"Lumbar Puncture","enrollment":60},{"nctId":"NCT07349082","phase":"NA","title":"Sensory Block Onset: Epidural vs Dural Puncture Epidural in Cesarean Section","status":"NOT_YET_RECRUITING","sponsor":"Gadjah Mada University","startDate":"2026-01-05","conditions":"Cesarean Section","enrollment":72},{"nctId":"NCT06496451","phase":"","title":"Measurement of Frataxin mRNA in Biofluids","status":"COMPLETED","sponsor":"University of Florida","startDate":"2024-08-08","conditions":"Friedreich Ataxia","enrollment":10},{"nctId":"NCT07221669","phase":"PHASE3","title":"A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)","status":"RECRUITING","sponsor":"Biogen","startDate":"2026-01-30","conditions":"Muscular Atrophy, Spinal","enrollment":30},{"nctId":"NCT07098364","phase":"PHASE1, PHASE2","title":"ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2025-12-27","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma","enrollment":33},{"nctId":"NCT06500481","phase":"PHASE3","title":"Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial","status":"RECRUITING","sponsor":"NRG Oncology","startDate":"2025-03-04","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Non-Small Cell Carcinoma","enrollment":115},{"nctId":"NCT05089656","phase":"PHASE3","title":"Efficacy and Safety of Intrathecal OAV101 (AVXS-101) in Pediatric Patients With Type 2 Spinal Muscular Atrophy (SMA)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2022-02-01","conditions":"Type 2 Spinal Muscular Atrophy","enrollment":126},{"nctId":"NCT03025256","phase":"PHASE1","title":"Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-05-02","conditions":"Acral Lentiginous Melanoma, Central Nervous System Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8","enrollment":71},{"nctId":"NCT05211336","phase":"PHASE1","title":"Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-04-19","conditions":"Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS), Aggressive B-cell Lymphoma With Secondary Involvement of the CNS","enrollment":14},{"nctId":"NCT07327801","phase":"NA","title":"The Impact of Ultrasound-Guided Spinal Anesthesia","status":"COMPLETED","sponsor":"Military Hospital of Tunis","startDate":"2025-02-01","conditions":"Ultrasound Guidance, Spinal Anesthesia, Procedural Performance","enrollment":136},{"nctId":"NCT06415344","phase":"PHASE3","title":"Long-term Extension of GTX-102 in Angelman Syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"Ultragenyx Pharmaceutical Inc","startDate":"2024-07-31","conditions":"Angelman Syndrome","enrollment":255},{"nctId":"NCT07312240","phase":"NA","title":"LONgitudinal and Integrated Evaluation of Biomarkers in reLation to phenotYpe in ALS","status":"RECRUITING","sponsor":"Istituto Auxologico Italiano","startDate":"2025-04-17","conditions":"Amyotrophic Lateral Sclerosis","enrollment":140},{"nctId":"NCT04453917","phase":"NA","title":"Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2021-02-23","conditions":"Progressive Multifocal Leukoencephalopathy","enrollment":22},{"nctId":"NCT07072585","phase":"PHASE2, PHASE3","title":"Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)","status":"NOT_YET_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2026-06-28","conditions":"Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma, Stage IV T Lymphoblastic Leukemia/Lymphoma","enrollment":1708},{"nctId":"NCT07304570","phase":"NA","title":"VR-Live Hybrid Neurosurgery Clerkship:Boosting Neurosurgical Presence & Decisions","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2023-03-01","conditions":"Virtual Reality, Telemedicine","enrollment":112},{"nctId":"NCT05761171","phase":"PHASE2","title":"A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2024-01-08","conditions":"Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage","enrollment":78},{"nctId":"NCT06816979","phase":"NA","title":"Lumbar Punctures for the Detection of ctDNA in the Cerebrospinal Fluid of Patients With Stage III and IV Non-Small Cell Lung Cancer","status":"NOT_YET_RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2026-01-15","conditions":"Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8","enrollment":40},{"nctId":"NCT05457556","phase":"PHASE3","title":"Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2023-03-15","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia","enrollment":435},{"nctId":"NCT06609889","phase":"PHASE1, PHASE2","title":"A Safety and Efficacy of Intrathecally Administered ION283 in Patients With Lafora Disease","status":"RECRUITING","sponsor":"Berge Minassian","startDate":"2024-12-03","conditions":"Lafora Disease","enrollment":10},{"nctId":"NCT03952637","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis","status":"RECRUITING","sponsor":"National Human Genome Research Institute (NHGRI)","startDate":"2019-08-19","conditions":"Lysosomal Diseases, Gangliosidosis, GM1","enrollment":54},{"nctId":"NCT06518057","phase":"PHASE2","title":"Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-03-03","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Non-Small Cell Carcinoma","enrollment":22},{"nctId":"NCT07256548","phase":"","title":"Machine Learning for Predicting Spinal Anesthesia Duration","status":"RECRUITING","sponsor":"Kocaeli City Hospital","startDate":"2025-10-31","conditions":"Spinal Anesthesia, Machine Learning, Knee Arthroplasty, Total","enrollment":140},{"nctId":"NCT06910761","phase":"PHASE2","title":"Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2025-05-05","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Non-Small Cell Carcinoma","enrollment":35},{"nctId":"NCT06589271","phase":"PHASE1","title":"SCLife®-LDD hUC-MSCs Injection Therapy for Patients With Lumbar Intervertebral Disc Degeneration","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Lumbar Disc Degeneration","enrollment":20},{"nctId":"NCT04403165","phase":"NA","title":"Locus-coeruleus Function in Normal Elderly and AD Risk","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2020-08-06","conditions":"Alzheimer Disease","enrollment":30},{"nctId":"NCT06638294","phase":"","title":"Study in Patients With Breast Cancer Leptomeningeal Metastasis","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2024-11-25","conditions":"Leptomeningeal Metastasis of Breast Cancer","enrollment":30},{"nctId":"NCT02003222","phase":"PHASE3","title":"Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-05-19","conditions":"Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative","enrollment":488}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10903,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"lumbar puncture","genericName":"lumbar puncture","companyName":"Shire","companyId":"shire","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":11,"withResults":3},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}